Chimeric Therapeutics (ASX:CHM) Other Long Term Assets : A$-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Chimeric Therapeutics Other Long Term Assets?

Chimeric Therapeutics's other long-term assets for the quarter that ended in Dec. 2023 was A$-0.00 Mil.

Chimeric Therapeutics's quarterly other long-term assets increased from Dec. 2022 (A$-0.00 Mil) to Jun. 2023 (A$0.00 Mil) but then stayed the same from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$-0.00 Mil).

Chimeric Therapeutics's annual other long-term assets declined from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) and declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

Chimeric Therapeutics Other Long Term Assets Historical Data

The historical data trend for Chimeric Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimeric Therapeutics Other Long Term Assets Chart

Chimeric Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Other Long Term Assets

Chimeric Therapeutics Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial			-	-	-	-	-

Chimeric Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Chimeric Therapeutics (ASX:CHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimeric Therapeutics Ltd (ASX:CHM) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CHMMF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.chimerictherapeutics.com

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.

Chimeric Therapeutics (ASX:CHM) Headlines

No Headlines